FDA Approves MEROPENEM — WG Critical Care, LLC
WG Critical Care, LLC announced the FDA approval of its Meropenem IV injection (NDA215212) on July 26, 2023, positioning the manufacturer to strengthen its portfolio against existing pan-bacterial competitors. This regulatory green light is expected to provide a critical alternative for treating severe infections, potentially capturing market share in the high-demand intravenous antimicrobial landscape.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed